NB
NBIX
Neurocrine Biosciences, Inc.
$156.22
1M -0.2%
3M -4.0%
YTD +11.1%
as of 2026-09-11
+Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· earnings ● beat ● miss
· ring ◯ before open ◯ after close
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -1.1% median,
45% of the last 29 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 57
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.06%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 0.64 -0.1% · Seasonal tilt -0.6%
$15.8B market cap (#764 US)
$160M/day volume
33% volatility
+11% 1-year
-16% from ATH
52-week range · 53% of the way up · -16% from the high
$122.14$186.12
Next report 2026-10-28 (Wednesday, after close, in 44 days) · EPS est. 2.72.
Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.